{"entity":{"type":"insider","cik":"0001766433","url":"/insider/0001766433","json_url":"/insider/0001766433.json","name":"Eckelman Brendan P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":13,"first":"2021-02-18","last":"2024-05-30","span_basis":"filed_date"},"name_variants":[{"name":"Eckelman Brendan P.","source":"filing","n_filings":13,"first_seen":"2021-02-18","last_seen":"2024-05-30"}],"transactions":[{"id":2234493,"accession":"0000950142-24-001497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-24-001497","line_url":"/filing/0000950142-24-001497#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":"0001766433","owner_name":"Eckelman Brendan P.","owner_url":"/insider/0001766433","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":34.3,"price_display":"34.30","price_state":"stated","total_value":10290000.0,"total_display":"10,290,000.00","shares_owned_after":1735553.0,"shares_owned_after_display":"1,735,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":8489514,"accession":"0001739614-23-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-23-000016","line_url":"/filing/0001739614-23-000016#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39600.0,"shares_display":"39,600","price_per_share":24.2007,"price_display":"24.20","price_state":"stated","total_value":958347.72,"total_display":"958,347.72","shares_owned_after":2035953.0,"shares_owned_after_display":"2,035,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8489507,"accession":"0001739614-23-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-23-000016","line_url":"/filing/0001739614-23-000016#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":24.7075,"price_display":"24.71","price_state":"stated","total_value":9883.0,"total_display":"9,883.00","shares_owned_after":2035553.0,"shares_owned_after_display":"2,035,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8049475,"accession":"0001739614-23-000012","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001739614-23-000012","line_url":"/filing/0001739614-23-000012#line-5","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10120.0,"shares_display":"10,120","price_per_share":25.4045,"price_display":"25.40","price_state":"stated","total_value":257093.54,"total_display":"257,093.54","shares_owned_after":2076683.0,"shares_owned_after_display":"2,076,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-02","scope":"insider"},{"id":8049472,"accession":"0001739614-23-000012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001739614-23-000012","line_url":"/filing/0001739614-23-000012#line-4","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1130.0,"shares_display":"1,130","price_per_share":25.8947,"price_display":"25.89","price_state":"stated","total_value":29261.011,"total_display":"29,261.01","shares_owned_after":2075553.0,"shares_owned_after_display":"2,075,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-02","scope":"insider"},{"id":8049469,"accession":"0001739614-23-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001739614-23-000012","line_url":"/filing/0001739614-23-000012#line-3","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14608.0,"shares_display":"14,608","price_per_share":25.0798,"price_display":"25.08","price_state":"stated","total_value":366365.7184,"total_display":"366,365.72","shares_owned_after":2087496.0,"shares_owned_after_display":"2,087,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8049466,"accession":"0001739614-23-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-23-000012","line_url":"/filing/0001739614-23-000012#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13449.0,"shares_display":"13,449","price_per_share":24.2925,"price_display":"24.29","price_state":"stated","total_value":326709.8325,"total_display":"326,709.83","shares_owned_after":2102104.0,"shares_owned_after_display":"2,102,104","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8049461,"accession":"0001739614-23-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-23-000012","line_url":"/filing/0001739614-23-000012#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":693.0,"shares_display":"693","price_per_share":25.6567,"price_display":"25.66","price_state":"stated","total_value":17780.0931,"total_display":"17,780.09","shares_owned_after":2086803.0,"shares_owned_after_display":"2,086,803","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":7852072,"accession":"0001739614-23-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001739614-23-000006","line_url":"/filing/0001739614-23-000006#line-5","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4102.0,"shares_display":"4,102","price_per_share":23.1072,"price_display":"23.11","price_state":"stated","total_value":94785.7344,"total_display":"94,785.73","shares_owned_after":2118556.0,"shares_owned_after_display":"2,118,556","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-04","scope":"insider"},{"id":7852069,"accession":"0001739614-23-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001739614-23-000006","line_url":"/filing/0001739614-23-000006#line-4","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3003.0,"shares_display":"3,003","price_per_share":23.9903,"price_display":"23.99","price_state":"stated","total_value":72042.8709,"total_display":"72,042.87","shares_owned_after":2115553.0,"shares_owned_after_display":"2,115,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-04","scope":"insider"},{"id":7852067,"accession":"0001739614-23-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001739614-23-000006","line_url":"/filing/0001739614-23-000006#line-3","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22213.0,"shares_display":"22,213","price_per_share":23.412,"price_display":"23.41","price_state":"stated","total_value":520050.756,"total_display":"520,050.76","shares_owned_after":2133340.0,"shares_owned_after_display":"2,133,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":7852065,"accession":"0001739614-23-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-23-000006","line_url":"/filing/0001739614-23-000006#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8598.0,"shares_display":"8,598","price_per_share":24.3575,"price_display":"24.36","price_state":"stated","total_value":209425.785,"total_display":"209,425.78","shares_owned_after":2124742.0,"shares_owned_after_display":"2,124,742","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":7852063,"accession":"0001739614-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-23-000006","line_url":"/filing/0001739614-23-000006#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2084.0,"shares_display":"2,084","price_per_share":25.0927,"price_display":"25.09","price_state":"stated","total_value":52293.1868,"total_display":"52,293.19","shares_owned_after":2122658.0,"shares_owned_after_display":"2,122,658","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":6689011,"accession":"0001739614-22-000128","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001739614-22-000128","line_url":"/filing/0001739614-22-000128#line-3","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20927.0,"shares_display":"20,927","price_per_share":26.8348,"price_display":"26.83","price_state":"stated","total_value":561571.8596,"total_display":"561,571.86","shares_owned_after":2174626.0,"shares_owned_after_display":"2,174,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-07","scope":"insider"},{"id":6689009,"accession":"0001739614-22-000128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000128","line_url":"/filing/0001739614-22-000128#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17681.0,"shares_display":"17,681","price_per_share":27.5716,"price_display":"27.57","price_state":"stated","total_value":487493.4596,"total_display":"487,493.46","shares_owned_after":2156945.0,"shares_owned_after_display":"2,156,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-07","scope":"insider"},{"id":6689007,"accession":"0001739614-22-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000128","line_url":"/filing/0001739614-22-000128#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1392.0,"shares_display":"1,392","price_per_share":28.4608,"price_display":"28.46","price_state":"stated","total_value":39617.4336,"total_display":"39,617.43","shares_owned_after":2155553.0,"shares_owned_after_display":"2,155,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-07","scope":"insider"},{"id":6642314,"accession":"0001739614-22-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000114","line_url":"/filing/0001739614-22-000114#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27651.0,"shares_display":"27,651","price_per_share":33.335,"price_display":"33.34","price_state":"stated","total_value":921746.085,"total_display":"921,746.08","shares_owned_after":2207902.0,"shares_owned_after_display":"2,207,902","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider"},{"id":6642311,"accession":"0001739614-22-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000114","line_url":"/filing/0001739614-22-000114#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12349.0,"shares_display":"12,349","price_per_share":33.9008,"price_display":"33.90","price_state":"stated","total_value":418640.9792,"total_display":"418,640.98","shares_owned_after":2195553.0,"shares_owned_after_display":"2,195,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider"},{"id":6378915,"accession":"0001739614-22-000105","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-7","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11136.0,"shares_display":"11,136","price_per_share":26.7764,"price_display":"26.78","price_state":"stated","total_value":298181.9904,"total_display":"298,181.99","shares_owned_after":2256762.0,"shares_owned_after_display":"2,256,762","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6378912,"accession":"0001739614-22-000105","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-6","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10893.0,"shares_display":"10,893","price_per_share":29.6798,"price_display":"29.68","price_state":"stated","total_value":323302.0614,"total_display":"323,302.06","shares_owned_after":2235653.0,"shares_owned_after_display":"2,235,653","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6378909,"accession":"0001739614-22-000105","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-5","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6207.0,"shares_display":"6,207","price_per_share":26.0614,"price_display":"26.06","price_state":"stated","total_value":161763.1098,"total_display":"161,763.11","shares_owned_after":2267898.0,"shares_owned_after_display":"2,267,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6378907,"accession":"0001739614-22-000105","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-4","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5954.0,"shares_display":"5,954","price_per_share":28.9713,"price_display":"28.97","price_state":"stated","total_value":172495.1202,"total_display":"172,495.12","shares_owned_after":2246546.0,"shares_owned_after_display":"2,246,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6378904,"accession":"0001739614-22-000105","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-3","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4262.0,"shares_display":"4,262","price_per_share":27.7566,"price_display":"27.76","price_state":"stated","total_value":118298.6292,"total_display":"118,298.63","shares_owned_after":2252500.0,"shares_owned_after_display":"2,252,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6378900,"accession":"0001739614-22-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1448.0,"shares_display":"1,448","price_per_share":24.6688,"price_display":"24.67","price_state":"stated","total_value":35720.4224,"total_display":"35,720.42","shares_owned_after":2274105.0,"shares_owned_after_display":"2,274,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6378896,"accession":"0001739614-22-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000105","line_url":"/filing/0001739614-22-000105#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Brendan P.; Eckelman Living Trust Dated February 5, 2014","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":30.52,"price_display":"30.52","price_state":"stated","total_value":3052.0,"total_display":"3,052.00","shares_owned_after":2235553.0,"shares_owned_after_display":"2,235,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6439880,"accession":"0001739614-22-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000095","line_url":"/filing/0001739614-22-000095#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37507.0,"shares_display":"37,507","price_per_share":14.857,"price_display":"14.86","price_state":"stated","total_value":557241.499,"total_display":"557,241.50","shares_owned_after":2438046.0,"shares_owned_after_display":"2,438,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-07","scope":"insider"},{"id":6439878,"accession":"0001739614-22-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000095","line_url":"/filing/0001739614-22-000095#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2493.0,"shares_display":"2,493","price_per_share":15.6567,"price_display":"15.66","price_state":"stated","total_value":39032.1531,"total_display":"39,032.15","shares_owned_after":2435553.0,"shares_owned_after_display":"2,435,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-07","scope":"insider"},{"id":6614575,"accession":"0001739614-22-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000077","line_url":"/filing/0001739614-22-000077#line-2","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15500.0,"shares_display":"15,500","price_per_share":18.4651,"price_display":"18.47","price_state":"stated","total_value":286209.05,"total_display":"286,209.05","shares_owned_after":2475553.0,"shares_owned_after_display":"2,475,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-04","scope":"insider"},{"id":6614574,"accession":"0001739614-22-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000077","line_url":"/filing/0001739614-22-000077#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24500.0,"shares_display":"24,500","price_per_share":17.699,"price_display":"17.70","price_state":"stated","total_value":433625.5,"total_display":"433,625.50","shares_owned_after":2491053.0,"shares_owned_after_display":"2,491,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-04","scope":"insider"},{"id":6734217,"accession":"0001739614-22-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000073","line_url":"/filing/0001739614-22-000073#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":17.17,"price_display":"17.17","price_state":"stated","total_value":686800.0,"total_display":"686,800.00","shares_owned_after":2515553.0,"shares_owned_after_display":"2,515,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-08","scope":"insider"},{"id":6989375,"accession":"0001739614-22-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000039","line_url":"/filing/0001739614-22-000039#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":25.04,"price_display":"25.04","price_state":"stated","total_value":10016.0,"total_display":"10,016.00","shares_owned_after":2555553.0,"shares_owned_after_display":"2,555,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-07","scope":"insider"},{"id":4441090,"accession":"0001739614-21-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-21-000051","line_url":"/filing/0001739614-21-000051#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":19.02,"price_display":"19.02","price_state":"stated","total_value":323340.0,"total_display":"323,340.00","shares_owned_after":2555953.0,"shares_owned_after_display":"2,555,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-24","filed_date":"2021-03-24","scope":"insider"},{"id":5308949,"accession":"0001739614-21-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-21-000040","line_url":"/filing/0001739614-21-000040#line-1","is_derivative":false,"issuer_cik":"0001739614","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001739614","owner_cik":null,"owner_name":"Eckelman Living Trust Dated February 5, 2014; Eckelman Brendan P.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":25.9,"price_display":"25.90","price_state":"stated","total_value":440300.0,"total_display":"440,300.00","shares_owned_after":2572953.0,"shares_owned_after_display":"2,572,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001739614","name":"Inhibrx, Inc.","url":"/issuer/0001739614","role":"Director, Officer (Chief Scientific Officer)","n_filings":13,"first_seen":"2021-02-18","last_seen":"2024-05-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001766433","retrieved_at":"2026-08-22T02:02:47+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}